NCT01526967

Brief Summary

The purpose of this study is to estimate the incidence and severity of peristomal skin lesions and evaluate the progression of the peristomal skin condition at 8-15 days following application of the barrier.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2012

Shorter than P25 for all trials

Geographic Reach
1 country

13 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 1, 2012

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 6, 2012

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
Last Updated

December 17, 2012

Status Verified

December 1, 2012

Enrollment Period

11 months

First QC Date

February 1, 2012

Last Update Submit

December 14, 2012

Conditions

Keywords

ostomyperistomal skin breakdownConvaTec Moldable Skin Barriers

Outcome Measures

Primary Outcomes (1)

  • Peristomal skin condition

    Change in peristomal skin condition from baseline as assessed with the SACS Instrument

    At day 12

Secondary Outcomes (6)

  • Peristomal skin condition

    at 1 month

  • Level of satisfaction

    At 2 months

  • Accessory usage

    Up to 2 months

  • Peristomal Skin Condition

    At 2 months

  • Level of satisfaction

    At 12 days

  • +1 more secondary outcomes

Study Arms (2)

New moldable user

Subjects presenting with peristomal lesions with a traditional barrier and for whom a ConvaTec Moldable Technology™ Skin Barrier is used as a replacement.

New osomate

Subjects for whom a ConvaTec Moldable Technology™ Skin Barrier is used as the first long-term (within 7 days of ostomy surgery) system following surgery and have intact peristomal skin.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

colostomates, ileostomates, urostomates in acute care settings or community at large.

You may qualify if:

  • Subjects who are 18 years old and older.
  • Subjects who agree to participate in the evaluation and who have signed the informed consent form.
  • Subjects presenting with a stoma (ileostomy, colostomy or urostomy).
  • Subjects for whom a ConvaTec Moldable Technology™ Skin Barrier per package insert is used as the first long-term (within 7 days of ostomy surgery) system following surgery and have intact peristomal skin.
  • Subjects presenting with peristomal skin lesions using a traditional barrier and for whom a decision to replace the traditional barrier with ConvaTec Moldable Technology™ Skin Barrier per package insert is made in the context of routine clinical care.

You may not qualify if:

  • Subjects who, according to the investigator, have cognitive problems that prevent them from answering a questionnaire or for whom the evaluation could be a problem.
  • Subjects who are in a simultaneous clinical evaluation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (13)

Independent Nurse Consultant

Tucson, Arizona, 85742, United States

Location

John Muir Health Concord Campus

Concord, California, 94520, United States

Location

Conn. Clinical Nursing Associate, LLC

Plymoth, Connecticut, 06782, United States

Location

Baptist Home Health

Jacksonville, Florida, 32207, United States

Location

Porter Hospital

Valparaiso, Indiana, 46383, United States

Location

Serena Group - Dr. Thomas Serena MD

Cambridge, Massachusetts, 02140, United States

Location

Henry Ford Macomb Hospital

Clinton Township, Michigan, 48038, United States

Location

Karmanos Cancer Center

Detroit, Michigan, 48201, United States

Location

St. Anthony's Medical Center

St Louis, Missouri, 63128, United States

Location

ID Med Inc.

Columbus, Ohio, 43222, United States

Location

RI Colorectal Clinic, LLC

Pawtucket, Rhode Island, 02860, United States

Location

San Jacinto Methodist Hospital

Baytown, Texas, 77521, United States

Location

NW Pavillion Ostomy Clinic

Renton, Washington, 98055, United States

Location

Study Officials

  • Qing Li, Ph.D, MD

    ConvaTec Inc.

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 1, 2012

First Posted

February 6, 2012

Study Start

January 1, 2012

Primary Completion

December 1, 2012

Study Completion

December 1, 2012

Last Updated

December 17, 2012

Record last verified: 2012-12

Locations